Patients with contraindications for colonoscopy or fecal transplantation.

Patients with acute or chronic infections with HIV, Tuberculosis, MDR Enterobacteria, CMV, parasites, fungi.

Patients with other causes of severe immunodeficiencies.

Lack of compliance with the conditions imposed by the research project.

Inclusion Criteria:

* Diagnosis of liver cirrhosis according to current protocols.
* Conscious and cooperative adult patients.

Exclusion Criteria:

* Patients with hemodynamic and/or respiratory instability.
* Patients with contraindications for colonoscopy or fecal transplantation.
* Patients with acute or chronic infections with HIV, Tuberculosis, MDR Enterobacteria, CMV, parasites, fungi.
* Associated oncological pathology.
* Patients with other causes of severe immunodeficiencies.
* Lack of compliance with the conditions imposed by the research project.
* Patients who do not sign the informed consent.

The study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology).

Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis

Summary